NSE · ROSSARI
Rossari Biotech Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#1,147
of 5,004 stocks
▼ 231W
Peak #1,122 · 27 Sep 2026
Operating in Healthcare, Rossari Biotech Limited remains firmly promoter-controlled, with promoters holding 68%, is growing revenue at a solid clip, and trades at a moderate earnings multiple.
Market Cap
2,315.03 Cr
P/E Ratio
15.51
P/B Ratio
1.74
ROE
11.19%
ROCE
15.28%
Dividend Yield
0.12%
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 697.20 Cr | 684.86 Cr | 581.68 Cr | 586.11 Cr |
| Net Profit | 35.10 Cr | 45.97 Cr | 32.77 Cr | 36.88 Cr |
| EPS | 6.34 | 8.30 | 5.92 | 6.66 |
| Operating Profit | 58.19 Cr | 72.79 Cr | 49.77 Cr | 55.30 Cr |
Shareholding pattern
Promoter
68.14%
Public
31.86%
Mutual fund holdings
₹249.44
Cr total
10
Schemes
3
Fund Houses
₹249.44 Cr
Total Exposure
UTI Mutual Fund₹170.90 Cr (68.5%)
Canara Robeco Mutual Fund₹49.71 Cr (19.9%)
Motilal Oswal Mutual Fund₹28.83 Cr (11.6%)
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 10 Jul 2026 | Dividend | Dividend - Rs 0.50 Per Share |
| 20 Jun 2025 | Dividend | Dividend - Re 0.50 Per Share |
| 04 Nov 2024 | Other | Extra Ordinary General Meeting |
| 16 Aug 2024 | Dividend | Annual General Meeting/Dividend - Re 0.50 Per Share |
| 24 May 2023 | Dividend | Annual General Meeting/Dividend - Re 0.50 Per Share |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.